Wave (WVE) Q1 2026 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Globe and Mail, The
Chief Medical Officer — Christopher Wright Chief Financial Officer — Kyle Moran Chief Development Officer — Erik Ingelsson Need a quote from a Motley Fool analyst? Email pr@fool.com Takeaways Revenue -- $38.2 million, reflecting an increase from $9.2 million, primarily due to recognition of revenue from regained WVE-006 rights and GSK collaboration progress. Research and development expenses -- $47.4 million, compared to $40.6 million, driven by ongoing advancement of clinical programs and pipeline expansion. General and administrative expenses -- $22.1 million, up from $18.4 million, as a result of costs supporting pipeline growth and next-phase development activities. Net loss -- $26.1 million for the first quarter of 2026, declining from $46.9 million in the prior year quarter. Cash balance -- $544.6 million at quarter end, with management stating this is expected to fund operations into the third quarter of 2028. WVE-007 (INHBE GalNAc-siRNA) -- Phase IIa trial
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- WAVE Life Sciences (WVE) was given a new $15.00 price target by Truist Financial Corporation.MarketBeat
- Wave (WVE) Q2 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Wave (WVE) Q1 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- WAVE Life Sciences Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 4/28/26 - Beat
WVE
Sec Filings
- 4/28/26 - Form 10-Q
- 4/28/26 - Form 8-K
- 4/21/26 - Form DEFA14A
- WVE's page on the SEC website